These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19917179)

  • 1. Adalimumab treatment of a patient with psoriasis suppurativa Hallopeau associated osteoarthropathy.
    Müeller RB; Ogilvie A; Schwarz S; Kern P; Schett G; Sticherling M
    Clin Exp Rheumatol; 2009; 27(5):887. PubMed ID: 19917179
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
    Tobin AM; Kirby B
    Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar.
    Megna M; Fabbrocini G; Costa C; Ferrillo M
    Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123
    [No Abstract]   [Full Text] [Related]  

  • 7. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
    Zhang Z; Wu X; Han C; Chen M; Liu Y
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
    [No Abstract]   [Full Text] [Related]  

  • 8. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
    Caputo F; Parro S; Zoli G
    J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
    [No Abstract]   [Full Text] [Related]  

  • 9. Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent.
    Callen JP; Jackson JH
    J Dermatolog Treat; 2005; 16(5-6):350-2. PubMed ID: 16428160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
    Dini V; Barbanera S; Romanelli M
    Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained efficacy and safety of adalimumab in psoriasis treatment: a retrospective study of 49 patients with and without a history of TNF-alpha antagonist treatment.
    Van L; Modi SV; Yang DJ; Hsu S
    Arch Dermatol; 2008 Jun; 144(6):804-6. PubMed ID: 18559778
    [No Abstract]   [Full Text] [Related]  

  • 14. Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series.
    Bhutani T; Koo J
    J Dermatolog Treat; 2011 Apr; 22(2):75-8. PubMed ID: 20524874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
    Wang Y; Zhang L; Zheng J; Li X; Chen L
    JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological treatment of psoriasis and psoriatic arthritis].
    Kragballe K; Deleuran B
    Ugeskr Laeger; 2008 Jun; 170(24):2148-50. PubMed ID: 18565300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrodermatitis continua of Hallopeau responding to efalizumab therapy.
    Balato N; Gallo L; Balato A; La Bella S; Ayala F
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1329-30. PubMed ID: 19250321
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply: To PMID 24530602.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1407. PubMed ID: 24614332
    [No Abstract]   [Full Text] [Related]  

  • 19. Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau.
    Rubio C; Martin MA; Arranz Sánchez DM; Vidaurrazaga C; Casado M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):707-8. PubMed ID: 18785890
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of biologic treatments for psoriasis with emphasis on infliximab.
    Pirzada S; Tomi Z; Gulliver W
    Skin Therapy Lett; 2007 Apr; 12(3):1-4. PubMed ID: 17487347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.